PNC-27 dosage chart

30 mg Vial

PNC-27 is dosed at 100 mcg–500 mcg daily via subcutaneous injection in educational protocols. A 30 mg vial reconstituted with bacteriostatic water yields about 10 mg/mL. This information is for research and educational use only.

Reconstitute: Add 3.0 mL bacteriostatic water → 10 mg/mL concentration.
Typical daily range: 100–500 mcg once daily (gradual titration).
Easy measuring: At 10 mg/mL, 1 unit = 0.01 mL = 100 mcg on a U‑100 insulin syringe.
Storage: Lyophilized: freeze at −20 °C (−4 °F); after reconstitution, refrigerate at 2–8 °C (35.6–46.4 °F); avoid freeze–thaw cycles.

Dosing schedule

Week	Daily Dose (mcg)	Units (per injection) (mL)
Weeks 1–2	100 mcg (0.10 mg)	1 unit (0.01 mL)
Weeks 3–4	200 mcg (0.20 mg)	2 units (0.02 mL)
Weeks 5–8	300 mcg (0.30 mg)	3 units (0.03 mL)
Weeks 9–12	400 mcg (0.40 mg)	4 units (0.04 mL)
Weeks 13–16	500 mcg (0.50 mg)	5 units (0.05 mL)

Reconstitution steps

1Draw 3.0 mL bacteriostatic water with a sterile syringe.
2Inject slowly down the vial wall; avoid foaming.
3Gently swirl/roll until dissolved (do not shake).
4Label and refrigerate at 2–8 °C (35.6–46.4 °F), protected from light.

Important Notes

Practical considerations for consistency and safety.

Use new sterile insulin syringes; dispose in a sharps container.
Rotate injection sites (abdomen, thighs, upper arms) to reduce local irritation.
Inject slowly; wait a few seconds before withdrawing the needle.
Document daily dose and site rotation to maintain consistency.
Regulatory Warning: PNC-27 has no FDA approval and no established human safety data. This information is strictly educational.

How This Works

PNC-27 is a chimeric peptide consisting of a segment derived from the p53 tumor suppressor protein (residues 12–26) fused to a membrane‑penetrating leader sequence. Preclinical studies indicate that PNC-27 selectively binds to HDM‑2 expressed on the surface of cancer cells, inducing membrane destabilization and necrotic cell death while sparing normal cells. Research in mouse tumor models has demonstrated inhibition of cancer cell growth via intraperitoneal administration. No human clinical studies have been conducted, and all dosing protocols remain theoretical extrapolations from preclinical work.

Potential Benefits & Side Effects

Observations from preclinical literature only—no human data available.

Preclinical studies suggest selective cytotoxicity toward cancer cells expressing abnormal p53/HDM‑2 while sparing normal cells.
Mechanism involves direct membrane lysis rather than apoptosis in affected cells.
No human safety data: The FDA explicitly warns that PNC-27 safety and efficacy have not been established.
Possible injection‑site reactions (redness, irritation) may occur with subcutaneous administration.

Lifestyle Factors

General supportive strategies (not specific to PNC-27).

Maintain a balanced, nutrient‑dense diet to support overall metabolic function.
Prioritize adequate sleep and stress management for immune and recovery support.
Consult qualified healthcare professionals before any experimental peptide use.

Injection Technique

General subcutaneous guidance from clinical best‑practice resources.

Clean the vial stopper and skin with alcohol; allow to dry.
Pinch a skinfold; insert the needle at 45–90° into subcutaneous tissue.
Do not aspirate for subcutaneous injections; inject slowly and steadily.
Rotate sites systematically (abdomen, thighs, upper arms) to avoid lipohypertrophy.

important-note

This content is for educational purposes only and is not medical advice. PNC-27 is an unapproved experimental compound with no established human safety or efficacy data.

PNC-27 dosage FAQs

How much bacteriostatic water do you use to reconstitute PNC-27?

Add 3.0 mL bacteriostatic water → 10 mg/mL concentration. for a 30 mg Vial vial. Add the water slowly against the inside wall of the vial and swirl — never shake — until the powder fully dissolves.

What does the PNC-27 dosing schedule look like?

Weeks 1–2 — 100 mcg (0.10 mg) — 1 unit (0.01 mL); Weeks 3–4 — 200 mcg (0.20 mg) — 2 units (0.02 mL); Weeks 5–8 — 300 mcg (0.30 mg) — 3 units (0.03 mL); Weeks 9–12 — 400 mcg (0.40 mg) — 4 units (0.04 mL). The full table above lists every step with matching syringe units.

What are the mixing steps for PNC-27?

Draw 3.0 mL bacteriostatic water with a sterile syringe. Inject slowly down the vial wall; avoid foaming. Gently swirl/roll until dissolved (do not shake).

How should reconstituted PNC-27 be stored?

Storage: Lyophilized: freeze at −20 °C (−4 °F); after reconstitution, refrigerate at 2–8 °C (35.6–46.4 °F); avoid freeze–thaw cycles..

How many insulin syringe units equal a PNC-27 dose?

Units depend on the water volume you used. Divide your target dose by the vial concentration to get millilitres, then multiply by 100 — 1 unit on a U-100 insulin syringe is 0.01 mL. The Spartan Peptides reconstitution calculator does this conversion for you.

Is PNC-27 approved for human use?

No. PNC-27 is sold and referenced strictly as a research chemical. Nothing on this page is medical advice and the material is not for human consumption.

Educational and research information only. Not medical advice, not for human consumption. Values are reference figures — always verify your own math with the reconstitution calculator.

On any insulin syringe, 1 unit = 0.01 mL, so unit counts above hold across brands.